CTOs on the Move

Orbus Therapeutics

www.orbustherapeutics.com

 
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Orbus Therapeutics raised $18M on 08/21/2015

Similar Companies

Hexagon Labs

Hexagon Labs is a Monmouth Junction, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

The Arc of Anchorage

The Arc of Anchorage is a Anchorage, AK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Isto Technologies, Inc

Isto Technologies, Inc is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Saint Louis, MO. To find more information about Isto Technologies, Inc, please visit www.istotech.com

Stormont-Vail HealthCare

Stormont-Vail HealthCare is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Stormont-Vail HealthCare is based in Topeka, KS. You can find more information on Stormont-Vail HealthCare at www.stormontvail.org

iWalk

iWalk is a Cambridge, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.